WHO ICTRP trial
Dexmedetomidine or clonidine infusion for prevention of delirium after open…
EUCTR2021-001645-12-NO · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2021-001645-12-NO |
|---|---|
| Public title | Dexmedetomidine or clonidine infusion for prevention of delirium after open heart surgery |
| Scientific title | Alpha 2 adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): randomised controlled trial. - Dexmedetomidine or clonidine infusion for prevention of delirium after open heart surgery |
| Primary sponsor | Oslo University Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): yes |
| Countries | Norway |
| Conditions | Postoperative delirium and cognitive decline in male and female participants aged 70+ scheduled for open heart surgery;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03] |
| Interventions | Product Name: Dexmedetomidine Pharmaceutical Form: Solution for infusion INN or Proposed INN: DEXMEDETOMIDINE CAS Number: 113775-47-6 Concentration unit: µg/µl microgram(s)/microlitre Concentration type: equal Concentration number: 0.4… |
| Registration date | Apr 28, 2021 |
| Target size | 900 |
| Secondary IDs | ALPHA2PREVENT;NCT05029050 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: